|
1HE9
Crystal structure of the GAP domain of the Pseudomonas aeruginosa ExoS toxin
提交 2000-11-21
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
102–235(134 aa)
片段:96-234 GTPASE-ACTIVATING PROTEIN (GAP-DOMAIN)
|
非标准单体:是(mmCIF未提供具体位点)
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 5.5;MGCL2, (NH4)2SO4, PEG 6000, NA-CACODYLATE PH5.5, pH 5.50
|
分辨率 2.40 Å
R-free 0.265
|
|
2C23
14-3-3 Protein Beta (Human) in complex with exoenzyme S peptide
提交 2005-09-26
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 P
421–431(11 aa)
片段:14-3-3 BINDING REGION, RESIDUES 421-431
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 8;0.05M MGCL2,0.1M HEPES PH7.5, 30% PEG MME 550, pH 8.00
|
分辨率 2.65 Å
R-free 0.286
|
|
6GN0
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, tetrameric crystal form
提交 2018-05-29
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 E
234–453(220 aa)
链 G
234–453(220 aa)
|
突变:E379A, E381A
突变:E379A, E381A
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5;277 K;12% PEG 3350, 4% Tacsimate
|
分辨率 3.24 Å
R-free 0.294
|
|
6GN0
Exoenzyme S from Pseudomonas aeruginosa in complex with human 14-3-3 protein beta, tetrameric crystal form
提交 2018-05-29
|
构建体不同
突变/修饰不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 F
234–453(220 aa)
链 H
234–453(220 aa)
|
突变:E379A, E381A
突变:E379A, E381A
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5;277 K;12% PEG 3350, 4% Tacsimate
|
分辨率 3.24 Å
R-free 0.294
|
|
6Y7T
Engineered conjugation of lysine-specific molecular tweezers with ExoS derived peptidic inhibitor enhance affinity towards target protein 14-3-3 through ditopic binding
提交 2020-03-02
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:TRIMERIC
|
链 D
420–430(11 aa)
|
未记录
|
NA SODIUM ION × 3
GOL GLYCEROL × 1
TWZ 2-[4-[2-[hydroxy-[[(1R,5S,9S,16R,20R,24S,28S,35R)-22-phosphonooxy-3-tridecacyclo[22.14.1.15,20.19,16.128,35.02,23.04,21.06,19.08,17.010,15.025,38.027,36.029,34]dotetraconta-2,4(21),6(19),7,10,12,14,17,22,25(38),26,29,31,33,36-pentadecaenyl]oxy]phosphoryl]oxyethyl]triazol-1-yl]acetic acid × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;Bis-Tris Propane
0.2M sodium acetate trihydrate
20% PEG1000
10% Glycerol
pH 7
Grew at 4 degree Celsius after a few days
|
分辨率 2.50 Å
R-free 0.268
|
|
6Y7T
Engineered conjugation of lysine-specific molecular tweezers with ExoS derived peptidic inhibitor enhance affinity towards target protein 14-3-3 through ditopic binding
提交 2020-03-02
|
构建体不同
聚集状态不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 3
PDB 声明:TRIMERIC
|
链 E
420–430(11 aa)
|
未记录
|
NA SODIUM ION × 2
GOL GLYCEROL × 1
TWZ 2-[4-[2-[hydroxy-[[(1R,5S,9S,16R,20R,24S,28S,35R)-22-phosphonooxy-3-tridecacyclo[22.14.1.15,20.19,16.128,35.02,23.04,21.06,19.08,17.010,15.025,38.027,36.029,34]dotetraconta-2,4(21),6(19),7,10,12,14,17,22,25(38),26,29,31,33,36-pentadecaenyl]oxy]phosphoryl]oxyethyl]triazol-1-yl]acetic acid × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;277 K;Bis-Tris Propane
0.2M sodium acetate trihydrate
20% PEG1000
10% Glycerol
pH 7
Grew at 4 degree Celsius after a few days
|
分辨率 2.50 Å
R-free 0.268
|